Emerald Advisers’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82K | Buy |
1,256
+1,012
| +415% | +$66K | ﹤0.01% | 227 |
|
|
2025
Q1 | $16.3K | Hold |
244
| – | – | ﹤0.01% | 238 |
|
|
2024
Q4 | $13.5K | Hold |
244
| – | – | ﹤0.01% | 250 |
|
|
2024
Q3 | $14.6K | Hold |
244
| – | – | ﹤0.01% | 243 |
|
|
2024
Q2 | $15.5K | Hold |
244
| – | – | ﹤0.01% | 243 |
|
|
2024
Q1 | $16.9K | Hold |
244
| – | – | ﹤0.01% | 239 |
|
|
2023
Q4 | $13.5K | Sell |
244
-174,033
| -100% | -$9.6M | ﹤0.01% | 237 |
|
|
2023
Q3 | $10.1M | Buy |
174,277
+1
| +0% | +$58 | 0.49% | 89 |
|
|
2023
Q2 | $9.38M | Sell |
174,276
-199,130
| -53% | -$10.7M | 0.41% | 93 |
|
|
2023
Q1 | $14.8M | Sell |
373,406
-69,830
| -16% | -$2.77M | 0.71% | 66 |
|
|
2022
Q4 | $17.8M | Sell |
443,236
-13,512
| -3% | -$544K | 0.86% | 49 |
|
|
2022
Q3 | $14.7M | Buy |
456,748
+868
| +0.2% | +$27.9K | 0.76% | 56 |
|
|
2022
Q2 | $13.5M | Buy |
455,880
+101,835
| +29% | +$3.02M | 0.7% | 60 |
|
|
2022
Q1 | $9.95M | Buy |
354,045
+271,101
| +327% | +$7.62M | 0.38% | 97 |
|
|
2021
Q4 | $3.82M | Buy |
+82,944
| New | +$3.82M | 0.14% | 123 |
|
|
2014
Q4 | – | Sell |
-115,440
| Closed | -$3.27M | – | 340 |
|
|
2014
Q3 | $3.27M | Buy |
115,440
+2,150
| +2% | +$60.8K | 0.19% | 155 |
|
|
2014
Q2 | $3.9M | Buy |
113,290
+41,270
| +57% | +$1.42M | 0.22% | 147 |
|
|
2014
Q1 | $2.26M | Buy |
+72,020
| New | +$2.26M | 0.13% | 186 |
|